Table 1. Baseline Characteristics.
| Characteristics | N (%), n = 58 |
|---|---|
| Gender, No. (%) | |
| Male | 29 (50) |
| Female | 29 (50) |
| Mean Age, year (range) | 65.9 (42–83) |
| ECOGa Performance status, No. (%) | |
| 0 or 1 | 29 (50) |
| ≥ 2 | 29 (50) |
| Smoking, No. (%) | |
| Never smoker | 47 (81) |
| Smoker | 11 (19) |
| Body weight loss, No. (%) | |
| Yes | 10 (17.2) |
| No | 48 (82.8) |
| EGFR mutation status | |
| 19 Del | 25 (43.1) |
| L858R | 33 (56.9) |
| EGFR TKI | |
| Gefitinib | 40 (70.2) |
| Erlotinib | 18 (29.8) |
| Clinical Response, No. (%) | |
| CRb | 5 (8.6) |
| PRc | 41 (70.6) |
| SDd | 10 (17.2) |
| PD | 2 (3.4) |
| Disease Free Survival, Median, (95% CI) | 10.2 (8.8–11.5) |
| Overall Survival, Median, (95% CI) | 23.4 (18.6–28.3) |